Sanyal Sabyasachi, Kim Joon-Young, Kim Han-Jong, Takeda Jun, Lee Yoon-Kwang, Moore David D, Choi Hueng-Sik
Department of Biology, Hormone Research Center, Chonnam National University, Kwangju, 500-757, Republic of Korea.
J Biol Chem. 2002 Jan 18;277(3):1739-48. doi: 10.1074/jbc.M106140200. Epub 2001 Nov 8.
The orphan nuclear receptor small heterodimer partner (SHP; NR0B2) interacts with a wide array of nuclear receptors and represses their transcriptional activity. SHP expression is regulated by several other members of the nuclear receptor superfamily, including the orphan receptors SF-1 and LRH-1, and the bile acid receptor FXR. We have found that the SHP promoter is also activated by the estrogen receptor-related receptor gamma (ERRgamma) but not the related ERRalpha and ERRbeta isoforms. SHP and ERRgamma mRNAs are coexpressed in several tissues, including pancreas, kidney, and heart, confirming the potential relevance of this transactivation. ERRgamma transactivation is dependent on only one of five previously characterized DNA-binding sites for SF-1, and this element differs from previously reported ERR response elements. However, treatment with the histone deacetylase inhibitor trichostatin A significantly increased ERRalpha and ERRbeta activity on this element indicating that the lack of activity of ERRalpha and -beta may depend on their association with co-repressor in vivo. Furthermore, using protease sensitivity assays on DNA bound receptors it was demonstrated that DNA sequence of different response elements may cause allosteric modulation of ERR proteins, which in turn may be responsible for the differential activities of these receptors on different response elements. SHP inhibits ERRgamma transactivation and physically interacts with all three members of ERR subfamily, as demonstrated by both yeast two-hybrid and biochemical assays. As with other SHP targets, this interaction is dependent on the AF-2 coactivator-binding site of ERRgamma and the previously described N-terminal receptor interaction domain of SHP. Several recently described SHP mutations associated with moderate obesity in humans block the inhibition of ERRgamma activity. Overall, these results identify a new autoregulatory loop controlling SHP gene expression and significantly extend the potential functional roles of the three ERRs.
孤儿核受体小异源二聚体伴侣(SHP;NR0B2)与多种核受体相互作用,并抑制它们的转录活性。SHP的表达受核受体超家族的其他几个成员调控,包括孤儿受体SF-1和LRH-1,以及胆汁酸受体FXR。我们发现,SHP启动子也可被雌激素受体相关受体γ(ERRγ)激活,但不被相关的ERRα和ERRβ亚型激活。SHP和ERRγ mRNA在包括胰腺、肾脏和心脏在内的多种组织中共同表达,证实了这种反式激活的潜在相关性。ERRγ反式激活仅依赖于SF-1五个先前确定的DNA结合位点中的一个,且该元件不同于先前报道的ERR反应元件。然而,用组蛋白脱乙酰酶抑制剂曲古抑菌素A处理可显著增加ERRα和ERRβ对该元件的活性,表明ERRα和ERRβ缺乏活性可能取决于它们在体内与共抑制因子的结合。此外,通过对与DNA结合的受体进行蛋白酶敏感性分析表明,不同反应元件的DNA序列可能导致ERR蛋白的变构调节,这反过来可能是这些受体在不同反应元件上具有不同活性的原因。SHP抑制ERRγ反式激活,并与ERR亚家族的所有三个成员发生物理相互作用,酵母双杂交和生化分析均证实了这一点。与其他SHP靶点一样,这种相互作用依赖于ERRγ的AF-2共激活因子结合位点和SHP先前描述的N端受体相互作用结构域。最近描述的几种与人类中度肥胖相关的SHP突变可阻断对ERRγ活性的抑制。总体而言,这些结果确定了一个控制SHP基因表达的新的自调节环,并显著扩展了三种ERRs的潜在功能作用。